Last update 08 May 2025

SEZ6 x DNA

Basic Info

Related Targets
SEZ6DNA

Related

1
Drugs associated with SEZ6 x DNA
SC-011
Target
DNA x SEZ6
Mechanism
DNA inhibitors [+1]
Active Org.
AbbVie, Inc.AbbVie, Inc.
Originator Org.
AbbVie, Inc.AbbVie, Inc.
Active Indication
Recurrent Lung Small Cell Carcinoma
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with SEZ6 x DNA
NCT03639194
/ CompletedPhase 1
A Phase I Study of ABBV-011 as a Single-Agent and in Combination With Budigalimab (ABBV-181) in Subjects With Relapsed or Refractory Small Cell Lung Cancer
100 Clinical Results associated with SEZ6 x DNA
Login to view more data
100 Translational Medicine associated with SEZ6 x DNA
Login to view more data
0 Patents (Medical) associated with SEZ6 x DNA
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free